Epidermal Growth Factor Receptor Activation Differentially Regulates Claudin Expression and Enhances Transepithelial Resistance in Madin-Darby Canine Kidney Cells
Open Access
- 1 January 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (5) , 3543-3552
- https://doi.org/10.1074/jbc.m308682200
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC)Lung Cancer, 2003
- The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cellsSeminars in Oncology, 2003
- ErbB-targeted therapeutic approaches in human cancerExperimental Cell Research, 2003
- The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumorsSeminars in Oncology, 2003
- Claudin-based tight junctions are crucial for the mammalian epidermal barrierThe Journal of cell biology, 2002
- Sustained Activation of Extracellular Signal-regulated Kinase Stimulated by Hepatocyte Growth Factor Leads to Integrin α2 Expression That Is Involved in Cell ScatteringJournal of Biological Chemistry, 2001
- Localization and modulation of ErbB receptor tyrosine kinasesCurrent Opinion in Cell Biology, 2001
- Claudin-1 contributes to the epithelial barrier function in MDCK cellsEuropean Journal of Cell Biology, 1999
- The epidermal growth factor/transforming growth factor-?? family and their receptorsEuropean Journal of Gastroenterology & Hepatology, 1995
- Morphological factors influencing transepithelial permeability: A model for the resistance of theZonula OccludensThe Journal of Membrane Biology, 1978